Home > Insider Trading > Filing (0001185185-18-000392)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1530766	Biosig Technologies Inc.	BSGM	Electromedical & Electrotherapeutic Apparatus (3845)	264333375

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1733727	Joseph Rafferty	C/O Biosig Technologies, Inc. 12424 Wilshire Blvd., Suite 745 Los Angeles CA 90025	Chief Commercialization Offcr	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-05	7,000	$1.40	7,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2017-11-24	420,000	$0.00	420,000	$1.45

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
420,000		2027-11-24	No	4	A	Direct

Footnotes

120,000 of the optioned shares vested on November 24, 2017. The remaining optioned shares shall vest as follows: (i) 50,000 on November 24, 2019; (ii) 100,000 shares on the date that the first entity to have a PURE EP System installed converts to a paying customer of the company; (iii) 50,000 on the date that the company first files financial statements with the U.S. Securities and Exchange Commission on Form 10-K or Form 10-Q that report revenues, calculated in accordance with generally accepted accounting principles; and (iv) 100,000 on the date that the company first files financial statements with the U.S. Securities and Exchange Commission on Form 10-K that report annual revenues of at least $10,000,000, calculated in accordance with generally accepted accounting principles.